[Methadone and new antiretroviral drugs. Results of therapeutic follow-up].
Touzeau
D
D
Département de Soins aux Toxicomanes, Clinique Liberté, CH Paul-Guiraud, Villejuif.
Beauverie
P
P
Bouchez
J
J
Poisson
N
N
Edel
Y
Y
Dessalles
M C
MC
Lherm
J
J
Furlan
V
V
Lagarde
B
B
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D001682:Biological Availability; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D006801:Humans; D008657:Metabolic Clearance Rate / Q000187:drug effects; D008691:Methadone / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D008691:Methadone